EUVIMEDEUVIMED entdecken
Crossref

A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation Defects

Mahtab Ramezani iD, Ali Asghar Okhovat iD, Yalda Nilipour iD, Aida Ghasemi iD, Bahram Haghi Ashtiani iD, Payam Sarraf, Ariana Kariminejad iD, Shahriar Nafissi iD

Muscle & Nerve · 2026

DOI: 10.1002/mus.70083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2026. Verfasst von Mahtab Ramezani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Myasthenic Syndromes, Congenital. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Glycosylation defects are a recognized cause of congenital myasthenic syndrome (CMS), affecting the stability and functions of the neuromuscular junction proteins. Mutations in five genes ( GFPT1 , DPAGT1 , GMPPB , ALG2 , and ALG14 ) are currently associated with glycosylation‐related CMS. This cohort describes Iranian patients with CMS and variants in these genes.

Methods

A retrospective study was conducted to examine demographic, clinical, genetic, and histological data from Iranian patients with confirmed CMS‐glycosylation defects. Patients were identified and recruited through the Neuromuscular Clinics of Tehran University of Medical Sciences. Only patients with complete clinical and genetic data available were included.

Results

Twenty‐three genetically confirmed patients with glycosylation‐related CMS were enrolled. Genetic analysis revealed the mutations in the GFPT1 , GMPPB , and ALG2 genes, with those in GFPT1 and GMPPB being the most common. The median age of onset and diagnosis was 6 and 16 years, respectively. Common clinical features were limb‐girdle muscle weakness with minimal ocular involvement. Consanguinity and a positive family history were common, identified in 21 and 14 patients, respectively. Muscle biopsies revealed tubular aggregates in patients with GFPT1 and GMPPB variants. In addition, novel genetic variants were identified, and phenotypic variability was observed even within families sharing identical mutations.

Discussion

This study identifies novel variants and phenotypic variability in glycosylation‐related CMS, with GFPT1 and GMPPB as the predominant subtypes in Iran. These findings expand the genotypic and phenotypic spectrum and underscore the importance of early genetic testing in high‐consanguinity populations to improve diagnosis and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenic Syndromes, CongenitalHumansMaleFemaleIranChildAdolescentRetrospective StudiesChild, PreschoolYoung AdultMutationAdultN-AcetylglucosaminyltransferasesGlycosylationCohort StudiesNucleotidyltransferasesGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)

Stichwörter der Autor:innen

ALG2GFPT1GMPPBcongenital myasthenic syndromesglycosylation defectneuromuscular junction

Substanzen

N-AcetylglucosaminyltransferasesGFPT1 protein, humanNucleotidyltransferasesGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)mannose 1-phosphate guanylyltransferase

Autor:innen und Institutionen

  • Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Neurology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Pediatric Pathology Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Neurology Department, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Neurology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Kariminejad-Najmabadi Pathology and Genetics Center, Tehran, Iran.

ORCID-Profile: Mahtab Ramezani, Ali Asghar Okhovat, Yalda Nilipour, Aida Ghasemi, Bahram Haghi Ashtiani, Ariana Kariminejad, Shahriar Nafissi

Zitieren

APA

Ramezani, M., Okhovat, A. A., Nilipour, Y., Ghasemi, A., Ashtiani, B. H., Sarraf, P., Kariminejad, A., & Nafissi, S. (2026). A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation Defects. Muscle & Nerve. https://doi.org/10.1002/mus.70083

Vancouver

Ramezani M, Okhovat AA, Nilipour Y, Ghasemi A, Ashtiani BH, Sarraf P, et al. A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation Defects. Muscle & Nerve. 2026. doi:10.1002/mus.70083

BibTeX
@article{Ramezani2026,
  author = {Ramezani, Mahtab and Okhovat, Ali Asghar and Nilipour, Yalda and Ghasemi, Aida and Ashtiani, Bahram Haghi and Sarraf, Payam and Kariminejad, Ariana and Nafissi, Shahriar},
  title = {A Cohort of Iranian Patients With Congenital Myasthenic Syndrome due to Glycosylation Defects},
  journal = {Muscle & Nerve},
  year = {2026},
  doi = {10.1002/mus.70083}
}
Kostenlos starten →